Deerfield Management’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-1,519,718
| Closed | -$71.3M | – | 104 |
|
|
2019
Q4 | $71.3M | Sell |
1,519,718
-208,301
| -12% | -$9.78M | 2.28% | 12 |
|
|
2019
Q3 | $40.9M | Buy |
1,728,019
+15,019
| +0.9% | +$355K | 1.67% | 16 |
|
|
2019
Q2 | $51.5M | Buy |
1,713,000
+211,000
| +14% | +$6.34M | 1.85% | 13 |
|
|
2019
Q1 | $33.6M | Hold |
1,502,000
| – | – | 1.29% | 26 |
|
|
2018
Q4 | $27.3M | Buy |
1,502,000
+1,119,300
| +292% | +$20.4M | 1.09% | 34 |
|
|
2018
Q3 | $6.92M | Hold |
382,700
| – | – | 0.25% | 80 |
|
|
2018
Q2 | $3.81M | Hold |
382,700
| – | – | 0.13% | 100 |
|
|
2018
Q1 | $2.03M | Buy |
382,700
+303,550
| +384% | +$1.61M | 0.07% | 109 |
|
|
2017
Q4 | $673K | Sell |
79,150
-23,000
| -23% | -$196K | 0.03% | 97 |
|
|
2017
Q3 | $1.49M | Buy |
102,150
+19,557
| +24% | +$285K | 0.07% | 90 |
|
|
2017
Q2 | $1.55M | Sell |
82,593
-95,237
| -54% | -$1.78M | 0.08% | 79 |
|
|
2017
Q1 | $3.79M | Sell |
177,830
-145,800
| -45% | -$3.1M | 0.15% | 89 |
|
|
2016
Q4 | $4.92M | Buy |
+323,630
| New | +$4.92M | 0.2% | 76 |
|